2010
DOI: 10.1016/j.jep.2010.01.015
|View full text |Cite
|
Sign up to set email alerts
|

Immunomodulatory potential of rhizome and seed extracts of Nelumbo nucifera Gaertn.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
42
0
1

Year Published

2011
2011
2023
2023

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 72 publications
(44 citation statements)
references
References 23 publications
1
42
0
1
Order By: Relevance
“…The treatment and grouping protocol were as mentioned in Section 2.2.5. On the 5th day of immunization, the animals were again challenged with 20 L of a challenging dose of 0.5 × 10 9 cells SRBCs in the right hind paw (Mukherjee et al, 2010). The thickness of the paw was measured before and after challenge of antigen administration.…”
Section: Immunization and Treatmentmentioning
confidence: 99%
“…The treatment and grouping protocol were as mentioned in Section 2.2.5. On the 5th day of immunization, the animals were again challenged with 20 L of a challenging dose of 0.5 × 10 9 cells SRBCs in the right hind paw (Mukherjee et al, 2010). The thickness of the paw was measured before and after challenge of antigen administration.…”
Section: Immunization and Treatmentmentioning
confidence: 99%
“…Correa ex, [18][19] Bacopa monnieri, 20 Solanum nigrum Linn., 21 Plumbago zeylanica L., [22][23][24] Coriandrum sativum Linn., 25 Leucas aspera (Willd.) Link, 26 Tinospora cordifolia (Wild) Meirs., [27][28][29][30][31][32][33][34][35][36][37][38][39][40] Terminalia chebula Retz., 41 Premna integrifolia Linn., 42 Carum carvi L., 43 Piper longum L., [44][45][46][47][48][49] Centella asiatica Linn., [50][51] Cyperus rotundus L., 52 Vitex nirgundo L., 53 Nelumbo nucifera Gaertn., [54][55] Moringa oleifera Lam., [56][57] Cedrus deodara (Roxb.) Loud., 58 Acorus calamus L., 2 Boerhavia diffusa Linn., 59 Embelia ribes Burn F., 2 Citrullus colocynthis Schrad., 60 Terminalia bellerica (Gaertn.)…”
Section: Discussionunclassified
“…These reactions require a specific antigenic substance which will release cytokines by activation with T-lymphocytes. [26] DTH is a part of the process of graft rejection, tumour immunity and most important immunity to many intracellular infectious micro-organisms, especially those causing chronic diseases viz., tuberculosis. In this study, SRBC was used as the antigenic substance which elicits the hypersensitivity reaction in mice.…”
Section: Discussionmentioning
confidence: 99%